DEA Extends COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for 6 Months
What You Should Know:Today, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a…
Continue Reading